Add to Favourites
To login click here
SwRI has developed a unique technology using their Rhodium™ software to screen potential DNA-targeting therapeutics for cancer and other diseases. This advanced application combines 3D drug screening and machine learning techniques to efficiently predict DNA binding affinity and cancer cell toxicity for various drug compounds. The technology aims to design more effective treatments for cancer and other diseases by targeting DNA.